Sensyne Health signs third US partnership agreement

Clinical AI company Sensyne Health has signed a new Strategic Research Agreement (SRA) with US-based healthcare provider Sentara Healthcare. Under the deal, Sensyne will have access to de-identified patient data covering Sentara’s 3.6 million patients and the two companies will collaborate on new clinical algorithms to support patients with chronic kidney disease and congestive heart failure….

You must be a HM Subscriber to view this content.

Subscribe Now »